贝贝林的抗发作作用和机制:系统性审查
Nahid Jivad1, Saeid Heidari-Soureshjani2, Hesamaldin Bagheri3
1Department of Neurology, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Current pharmaceutical biotechnology
|February 22, 2024
概括
柏柏林 (BBR) 通过减少氧化应激和炎症,显示出显著的抗发作和神经保护作用. 建议进行进一步的临床试验,以探索其治疗的治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 是一种广泛和残疾的神经系统疾病,影响全球所有年龄组.
- 了解的潜在治疗剂对于改善患者的治疗结果至关重要.
研究的目的:
- 系统地审查柏柏林 (BBR) 的抗发作和抗作用.
- 调查BBR对的影响背后的潜在机制.
主要方法:
- 在2023年9月之前在主要数据库 (EMBASE,Scopus,Cochrane Library,PubMed,Web of Science) 进行全面的文献搜索.
- 包括所有研究类型,检查BBR对或化学诱导发作的影响.
- 由多个作者进行独立审查和数据提取,以确保准确性.
主要成果:
- 柏柏林 (BBR) 通过减轻氧化应激,神经炎症和亡,表现出神经保护性质.
- BBR增强脑衍生神经营养因子 (BDNF),并调节包括TGF-β1,HIF-1α,ROS,Nrf2,HO-1,IL-1β,IL-6,TNF-α,COX-2和NF-κB在内的通路.
- 观察到c-fos表达和神经元刺激性的调节表明它对大脑活动有直接影响.
结论:
- 柏柏林显示出有前途的抗发作潜力,其强大的抗氧化,抗炎,抗丧和神经保护作用是其支的.
- 专注于提高BBR生物可用性的精心设计的临床试验是有必要的,以验证其在治疗中的有效性.
更多相关视频
06:28Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems
Published on: September 27, 2024
2.3K
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
17.8K
相关概念视频
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
399
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
399
01:20Antiepileptic Drugs: Potassium Channel Activators
183
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
183
01:17Antiepileptic Drugs: Calcium Channel Blockers
401
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
401
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
301
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
301
01:08Antiepileptic Drugs: Sodium Channel Blockers
559
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
559
01:24Arteries of the Lower Limbs
189
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
189